Upon accumulation in the tumor site, these tumor-suppressive TAMs drive immune suppression and angiogenesis through anti-inflammatory factors such as arginase (Arg1), TGF-β, IL-10, and VEGF [68,69]. The gene discussed is TGFB1; the disease is neoplasm.